cropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.png
  • About REPRIEVE
    • Spread the Word about REPRIEVE!
    • REPRIEVE Insights Newsletter
    • Publications and Plain Language Summaries
    • Our Story
    • In the News
    • Study FAQ
  • Meet Our Team
    • Clinical Coordinating Center (CCC)
    • Data Coordinating Center (DCC)
    • Community Scientific Subcommittee (CSS)
    • REPRIEVE Community Advisory Board (CAB)
    • National Institutes of Health
  • For Participants
    • REPRIEVE 2023 Community Forums
    • Meet REPRIEVE Participants
  • Contact Us
✕

Contact Us

    Search

    ✕
     

    Recent News

    • ACTG Presents Important Findings from REPRIEVE at CROI 2025
      March 13, 2025
    • ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
      March 13, 2025
    ©2019 | This website, and any related materials applies only to REPRIEVE A5332.